Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-04-09Clinical Trial Update: NAL ER IPF Respiratory Function and Safety Study [Phase 1]
Phase 1 clinical trial update for NAL ER evaluating respiratory function and safety in idiopathic pulmonary fibrosis; recruiting is ongoing.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial [NA]
The OPTIMIZE-ILD-2 trial aims to optimize follow-up care for interstitial lung disease and fibrotic ILD, and it is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial is evaluating the safe and effective dose of CHF10067 (Zampilimab) for idiopathic pulmonary fibrosis, sponsored by …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Validation of the C-mo System - Cough Monitoring [NA]
This clinical trial update concerns validation of the C-mo System for cough monitoring, with recruitment ongoing across conditions including…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 clinical trial update evaluating the safety and potential efficacy of nebulized extracellular vesicles derived from 3D-cultured hu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Dyspnea and Idiopathic Pulmonary Fibrosis
A clinical trial investigating dyspnea in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis [Phase 3]
A Phase 3 trial evaluating inhaled treprostinil for idiopathic pulmonary fibrosis and interstitial lung disease has completed.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF [Phase 2]
A Phase 2 randomized study is evaluating the safety and efficacy of AP02 (Nintedanib Solution) in idiopathic pulmonary fibrosis and is curre…
-
FDA approval · 2026-04-02FDA Approved: NINTEDANIB — Original Application (Edenbridge Pharmaceuticals LLC.)
FDA approved the original application for a generic version of nintedanib, developed by Edenbridge Pharmaceuticals LLC.
-
FDA approval · 2026-04-02FDA Approved: NINTEDANIB — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the generic version of nintedanib from Dr. Reddy's Laboratories Inc. under an Original Application (ANDA 219283).
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease [Phase 3]
This is a Phase 3 extension study of inhaled treprostinil for fibrotic lung diseases, sponsored by United Therapeutics, with enrollment by i…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 trial evaluating MTX-463 for Idiopathic Pulmonary Fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
This is a Phase 2 trial evaluating axatilimab for idiopathic pulmonary fibrosis and it is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A PhaseⅠ Study of HW252001 in Healthy Subjects [Phase 1]
Phase I trial update for HW252001 in healthy subjects, with idiopathic pulmonary fibrosis listed as a condition and recruitment not yet star…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis [Phase 3]
A Phase 3 study to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis. The tri…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial [Phase 3]
Phase 3 PRECISIONS trial in idiopathic pulmonary fibrosis has completed, evaluating genotype-guided selection of N-acetylcysteine therapy.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 clinical study evaluating REGEND001 cell therapy for idiopathic pulmonary fibrosis has completed, assessing efficacy and safety.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis [Phase 3]
An ongoing Phase 3 trial is evaluating intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis. The study is cur…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 trial evaluating GSK3915393 for idiopathic pulmonary fibrosis was terminated, indicating the study did not continue to completion.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
This clinical trial update indicates a Phase 2 study evaluating CAL101 for idiopathic pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. [NA]
A clinical trial is evaluating whether quercetin intake benefits patients with fibrotic interstitial lung diseases, including idiopathic pul…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
An adaptive-design Phase 3 trial is evaluating the efficacy and safety of TDI01 suspension in idiopathic pulmonary fibrosis. The study is cu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers. [EARLY_Phase 1]
An early-phase 1 study evaluating the safety, tolerability, and pharmacokinetics of SV001 in Chinese healthy adult volunteers, with Idiopath…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD [NA]
Clinical trial update indicates expansion of pulmonary rehabilitation to treat chronic respiratory diseases beyond COPD, with the study curr…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF [NA]
Clinical trial evaluating whether CPAP affects abnormal gastroesophageal reflux and lung inflammation in idiopathic pulmonary fibrosis; the …